ScholarWorksIndianapolis
  • Communities & Collections
  • Browse ScholarWorks
  • English
  • Català
  • Čeština
  • Deutsch
  • Español
  • Français
  • Gàidhlig
  • Italiano
  • Latviešu
  • Magyar
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Suomi
  • Svenska
  • Türkçe
  • Tiếng Việt
  • Қазақ
  • বাংলা
  • हिंदी
  • Ελληνικά
  • Yкраї́нська
  • Log In
    or
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. Browse by Subject

Browsing by Subject "Dronabinol"

Now showing 1 - 10 of 11
Results Per Page
Sort Options
  • Loading...
    Thumbnail Image
    Item
    Association of Cannabis Use With Nausea and Vomiting of Pregnancy
    (Wolters Kluwer, 2022) Metz, Torri D.; Allshouse, Amanda A.; McMillin, Gwendolyn A.; Silver, Robert M.; Smid, Marcela C.; Haas, David M.; Simhan, Hyagriv N.; Saade, George R.; Grobman, William A.; Parry, Samuel; Chung, Judith H.; Jarlenski, Marian P.; Obstetrics and Gynecology, School of Medicine
    Our objective was to evaluate whether cannabis use was associated with nausea and vomiting in early pregnancy. Participants from nuMoM2b (Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-Be) enrolled from October 2010 through September 2013 with a PUQE (Pregnancy-Unique Quantification of Emesis) questionnaire and an available stored urine sample from the first study visit (median gestational age 12 weeks) were included. Cannabis exposure was ascertained by urine immunoassay for 11-nor-9-carboxy-delta-9-tetrahydrocannabinol (THC-COOH); positive results were confirmed with liquid chromatography tandem mass spectrometry. The primary outcome was moderate-to-severe nausea by the PUQE score. Overall, 9,250 participants were included, and 5.8% (95% CI 5.4-6.3%) had detectable urine THC-COOH. In adjusted analyses, higher THC-COOH levels were associated with greater odds of moderate-to-severe nausea (20.7% in the group with THC-COOH detected vs 15.5% in the group with THC-COOH not detected, adjusted odds ratio 1.6, 95% CI 1.1-2.2 for a 500 ng/mg Cr THC-COOH increment).
  • Loading...
    Thumbnail Image
    Item
    Cardiovascular pharmacology of 9-tetrahydrocannabinol
    (1972) Milzoff, Joel Robert
  • Loading...
    Thumbnail Image
    Item
    Clinical investigations with marihuana and alcohol
    (1970) Manno, Joseph E.
  • Loading...
    Thumbnail Image
    Item
    The combined effects of cannabichromene and delta-9-Tetrahydrocannabinol
    (1980) O'Neil, James Dennen
  • Loading...
    Thumbnail Image
    Item
    The combined effects of cannabidiol and delta-9-tetrahydrocannabinol
    (1974) McCoy, Daniel Joseph
  • Loading...
    Thumbnail Image
    Item
    The effects of delta-9-tetrahydrocannabinol and nabilone on respiratory smooth muscle
    (1979) Orzelek, Rita Maria
  • Loading...
    Thumbnail Image
    Item
    The identification, isolation, toxicity, and tissue distribution of [delta]⁹-tetrahydrocannabinol
    (1970) Turk, Robert Frank
  • Loading...
    Thumbnail Image
    Item
    The influence of cannabidiol on the effects of delta-9-tetrahydrocannabinol
    (1976) Dalton, William
  • Loading...
    Thumbnail Image
    Item
    The pharmacological activity of the acidic, basic, and polar neutral fractions of marihuana whole smoke condensate alone, and in combination with, delta-9-tetrahydrocannabinol
    (1981) Johnson, Jan M.
  • Loading...
    Thumbnail Image
    Item
    Synthesis and pharmacologic investigation of some cannabinol and tetrahydrocannabinol analogs
    (1967) Garriott, James C.
  • «
  • 1 (current)
  • 2
  • »
About IU Indianapolis ScholarWorks
  • Accessibility
  • Privacy Notice
  • Copyright © 2025 The Trustees of Indiana University